TVM Capital Life Science wraps up second fund at $478m

TVM Capital Life Science, a venture capital firm with offices in Munich, Germany and Montreal, Canada, has closed TVM Life Science Innovation II, raising US$478 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this